Shenzhen Lifotronic Technology Co (688389) - Net Assets

Latest as of March 2026: CN¥2.14 Billion CNY ≈ $313.58 Million USD

Based on the latest financial reports, Shenzhen Lifotronic Technology Co (688389) has net assets worth CN¥2.14 Billion CNY (≈ $313.58 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.53 Billion ≈ $369.58 Million USD) and total liabilities (CN¥382.72 Million ≈ $56.00 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 688389 tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥2.14 Billion
% of Total Assets	84.85%
Annual Growth Rate	21.31%
5-Year Change	67.63%
10-Year Change	N/A
Growth Volatility	19.48

Shenzhen Lifotronic Technology Co - Net Assets Trend (2016–2025)

This chart illustrates how Shenzhen Lifotronic Technology Co's net assets have evolved over time, based on quarterly financial data. See how many days can Shenzhen Lifotronic Technology Co fund operations to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Shenzhen Lifotronic Technology Co (2016–2025)

The table below shows the annual net assets of Shenzhen Lifotronic Technology Co from 2016 to 2025. For live valuation and market cap data, see 688389 stock market capitalisation.

Year	Net Assets	Change
2025-12-31	CN¥2.11 Billion ≈ $308.57 Million	+2.90%
2024-12-31	CN¥2.05 Billion ≈ $299.89 Million	+14.01%
2023-12-31	CN¥1.80 Billion ≈ $263.05 Million	+24.53%
2022-12-31	CN¥1.44 Billion ≈ $211.23 Million	+14.75%
2021-12-31	CN¥1.26 Billion ≈ $184.08 Million	+10.00%
2020-12-31	CN¥1.14 Billion ≈ $167.34 Million	+8.95%
2019-12-31	CN¥1.05 Billion ≈ $153.60 Million	+57.04%
2018-12-31	CN¥668.39 Million ≈ $97.81 Million	+13.82%
2017-12-31	CN¥587.25 Million ≈ $85.93 Million	+58.36%
2016-12-31	CN¥370.82 Million ≈ $54.26 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Shenzhen Lifotronic Technology Co's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 1952.5% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	CN¥929.52 Million	43.93%
Other Components	CN¥1.19 Billion	56.07%
Total Equity	CN¥2.12 Billion	100.00%

Shenzhen Lifotronic Technology Co Competitors by Market Cap

The table below lists competitors of Shenzhen Lifotronic Technology Co ranked by their market capitalization.

Company	Market Cap
AGF Management Limited F:A3J	$657.84 Million
Invesco Municipal Opportunity Trust NYSE:VMO	$658.22 Million
China Chippacking Technology Co. Ltd. A SHG:688216	$658.40 Million
Hubeiyichang Transportation Group Co Ltd SHE:002627	$658.46 Million
Zhongyin Babi Food Co. Ltd. SHG:605338	$657.65 Million
COMPASS PATHW SP.ADR F:5Y6	$657.30 Million
Raydium Semi-Conductor TW:3592	$657.21 Million
Bintulu Port Holdings Bhd KLSE:5032	$657.14 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Shenzhen Lifotronic Technology Co's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 2,050,964,593 to 2,115,784,957, a change of 64,820,364 (3.2%).
Net income of 186,094,700 contributed positively to equity growth.
Dividend payments of 120,832,975 reduced retained earnings.
Other comprehensive income decreased equity by 132,273,059.
Other factors increased equity by 131,831,698.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥186.09 Million	+8.8%
Dividends Paid	CN¥120.83 Million	-5.71%
Other Comprehensive Income	CN¥-132.27 Million	-6.25%
Other Changes	CN¥131.83 Million	+6.23%
Total Change	CN¥-	3.16%

Book Value vs Market Value Analysis

This analysis compares Shenzhen Lifotronic Technology Co's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.15x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has increased from 1.46x to 2.15x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	CN¥7.18	CN¥10.49	x
2017-12-31	CN¥1.67	CN¥10.49	x
2018-12-31	CN¥1.73	CN¥10.49	x
2019-12-31	CN¥2.71	CN¥10.49	x
2020-12-31	CN¥2.70	CN¥10.49	x
2021-12-31	CN¥2.97	CN¥10.49	x
2022-12-31	CN¥3.44	CN¥10.49	x
2023-12-31	CN¥4.21	CN¥10.49	x
2024-12-31	CN¥4.81	CN¥10.49	x
2025-12-31	CN¥4.89	CN¥10.49	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Shenzhen Lifotronic Technology Co utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 8.80%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 17.93%
• Asset Turnover: 0.37x
• Equity Multiplier: 1.33x
Recent ROE (8.80%) is below the historical average (12.33%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2016	2.80%	5.95%	0.35x	1.34x	CN¥-26.70 Million
2017	9.61%	22.50%	0.35x	1.21x	CN¥-2.30 Million
2018	12.14%	25.09%	0.40x	1.21x	CN¥14.30 Million
2019	9.58%	23.79%	0.36x	1.12x	CN¥-4.41 Million
2020	12.59%	25.99%	0.43x	1.13x	CN¥29.65 Million
2021	15.16%	24.46%	0.53x	1.17x	CN¥64.80 Million
2022	17.47%	25.58%	0.54x	1.26x	CN¥107.50 Million
2023	18.29%	28.68%	0.49x	1.30x	CN¥148.91 Million
2024	16.84%	30.09%	0.40x	1.41x	CN¥140.30 Million
2025	8.80%	17.93%	0.37x	1.33x	CN¥-25.48 Million

Industry Comparison

This section compares Shenzhen Lifotronic Technology Co's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $3,442,122,104
Average return on equity (ROE) among peers: 12.05%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Shenzhen Lifotronic Technology Co (688389)	CN¥2.14 Billion	2.80%	0.18x	$657.73 Million
Shanghai Kehua Bio-Engineering Co Ltd (002022)	$4.98 Billion	-4.70%	0.37x	$371.06 Million
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223)	$2.13 Billion	17.09%	0.37x	$3.63 Billion
Double Medical Technology Inc (002901)	$3.11 Billion	2.98%	0.27x	$2.56 Billion
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932)	$6.77 Billion	62.15%	0.36x	$506.97 Million
Lepu Medical Tech Beijing (300003)	$10.54 Billion	17.10%	0.73x	$3.19 Billion
INKON Life Technology Co Ltd (300143)	$343.97 Million	0.00%	1.34x	$764.39 Million
Edan Instruments Inc (300206)	$1.25 Billion	3.50%	0.14x	$1.15 Billion
Guangdong Biolight Meditech Co Ltd (300246)	$1.39 Billion	-4.69%	0.82x	$735.30 Million
Beijing Leadman Biochemistry Co Ltd (300289)	$761.02 Million	12.92%	0.49x	$467.29 Million
Sinocare Inc (300298)	$3.14 Billion	14.20%	0.47x	$1.17 Billion

About Shenzhen Lifotronic Technology Co

SHG:688389 China Medical Devices

Market Cap

$657.73 Million

CN¥4.49 Billion CNY

Market Cap Rank

#11019 Global

#3107 in China

Share Price

CN¥10.49

Change (1 day)

-0.47%

52-Week Range

CN¥10.49 - CN¥14.74

All Time High

CN¥37.22